Company Pulse Biosciences, Inc.

Equities

PLSE

US74587B1017

Advanced Medical Equipment & Technology

Delayed Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
8.71 USD +3.69% Intraday chart for Pulse Biosciences, Inc. -7.64% -28.84%

Business Summary

Pulse Biosciences, Inc. is a bioelectric medicine company. The Company uses Nano-Pulse Stimulation technology, an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. It has developed CellFX System, which is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. The CellFX System is configured to accept a variety of handpieces or electrodes across a range of clinical applications. It has developed a cardiac ablation clamp for use in cardiac surgery and a cardiac ablation catheter for use in electrophysiology. The Company's cardiac ablation clamp and cardiac ablation catheter both use the CellFX System to generate its proprietary pulses of electrical energy. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment.

Number of employees: 61

Sales per Business

USD in Million2021Weight2022Weight Delta
Systems
80.0 %
1 83.9 % 1 80.0 % -52.90%
Cycle Units
20.0 %
0 16.1 % 0 20.0 % -38.86%

Sales per region

USD in Million2021Weight2022Weight Delta
North America
73.9 %
1 83.4 % 1 73.9 % -56.26%
Rest of World
26.1 %
0 16.6 % 0 26.1 % -22.46%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 22-02-13
Chief Tech/Sci/R&D Officer - 23-05-02
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 17-03-31
Chief Tech/Sci/R&D Officer - 15-10-31
Chief Tech/Sci/R&D Officer 59 15-09-14
Corporate Officer/Principal 63 19-03-17
General Counsel - 18-05-10
Human Resources Officer - 20-02-29
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chairman 79 17-11-01
Director/Board Member 46 17-11-01
Chief Tech/Sci/R&D Officer 59 15-09-14
Director/Board Member 52 17-02-09
Director/Board Member 63 14-12-31
Director/Board Member 59 21-11-23
Director/Board Member 57 20-08-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,080,527 16,218,084 ( 29.44 %) 0 29.44 %

Shareholders

NameEquities%Valuation
37,827,813 68.77 % 374 M $
BlackRock Advisors LLC
1.869 %
1,028,096 1.869 % 10 M $
Bank of America, NA (Charlotte, North Carolina)
1.457 %
801,341 1.457 % 8 M $
752,985 1.369 % 7 M $
Vanguard Fiduciary Trust Co.
1.196 %
657,985 1.196 % 7 M $
Geode Capital Management LLC
0.6895 %
379,259 0.6895 % 4 M $
309,520 0.5627 % 3 M $
Griffin Asset Management, Inc.
0.4720 %
259,620 0.4720 % 3 M $
Northern Trust Investments, Inc.(Investment Management)
0.2830 %
155,655 0.2830 % 2 M $
150,893 0.2743 % 1 M $

Company contact information

Pulse Biosciences, Inc.

3957 Point Eden Way

94545, Hayward

+510 906 4600

http://www.pulsebiosciences.com
address Pulse Biosciences, Inc.(PLSE)